A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
BiOWiSH Technologies, Inc., a global provider of biotechnology solutions, has named Bill Diederich as Chief Executive Officer (CEO), effective immediately. Diederich, who has been with the company for ...
Ocugen, a U.S.-based biotechnology company, licensed the innovative technology from WashU in 2022 ... Gasser Professor of Medicine and the co-director of the Center for Vaccines & Immunity to ...
Technological Innovation: The rapid pace of technological innovation in single cell isolation, sequencing, and analysis techniques is a primary driver of market growth. These advancements have ...
Enduro Genetics – the synthetic biology startup transforming biomanufacturing by “addicting” cells to high production – has raised €12 million in Series A funding from Supernova Invest, NOON Ventures ...